Quickstart Highlights

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a gastric protein sequence studied for tissue-healing and cytoprotective properties^[1][2]. Preclinical models demonstrate accelerated wound repair and anti-inflammatory activity^[3], though human clinical data remain limited to early-phase safety trials and small case reports^[4][5]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

• Reconstitute: Add 3.0 mL bacteriostatic water → 1.67 mg/mL concentration.
• Typical daily range: 200–600 mcg once daily (gradual titration).
• Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 insulin syringe.
• Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Protocol Overview

Concise summary of the once-daily regimen.

• Goal: Support tissue-healing and recovery processes based on preclinical evidence^[1][3].
• Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
• Dose Range: 200–600 mcg daily with gradual titration.
• Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach.

• Start: 200 mcg daily; increase by ~200 mcg every 2 weeks as tolerated.
• Target: 400–600 mcg daily by Weeks 5–8+.
• Frequency: Once per day (subcutaneous).
• Cycle Length: 8–12 weeks; optional extension to 16 weeks.
• Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); prepare aliquots if needed and avoid freeze–thaw.
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes for each injection; dispose in a sharps container^[7].
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation^[8].
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose and site rotation to maintain consistency.
• BPC-157 human data are preliminary; clinical decisions should involve qualified healthcare providers.

How This Works

BPC-157 is a synthetic peptide corresponding to a partial sequence of human gastric juice protein^[2]. Preclinical studies suggest it modulates nitric oxide pathways and growth-factor expression to promote angiogenesis and collagen deposition in damaged tissues^[1][3]. Animal models report accelerated healing of gut, tendon, ligament, and muscle injuries^[6]. A Phase I oral safety trial has been completed^[9], and a small human case series reported improvements following intra-articular administration^[5]; however, large-scale controlled human efficacy data are not yet available.

Potential Benefits & Side Effects

Observations from preclinical and early clinical literature.

• Supports tissue repair in gut, tendon, muscle, and skin injury models (animal data)^[1][3].
• Demonstrates anti-inflammatory and cytoprotective properties in preclinical settings^[6].
• Phase I safety studies report good tolerability with no serious adverse events at tested doses^[9].
• Occasional mild injection-site reactions (redness, itch) may occur with subcutaneous administration.
• Long-term human safety and efficacy remain under investigation^[4].

Lifestyle Factors

Complementary strategies for best outcomes.

• Support recovery with adequate protein intake and micronutrient-rich foods.
• Balance activity and rest to allow tissue adaptation without overuse.
• Prioritize sleep and stress management to enhance natural healing processes.
• Consult qualified healthcare providers for injury-specific rehabilitation guidance.

Injection Technique

General subcutaneous guidance from clinical best-practice resources^[10][11].

• Clean the vial stopper and skin with alcohol; allow to dry.
• Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue^[10].
• Do not aspirate for subcutaneous injections; inject slowly and steadily^[10].
• Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy^[8].
• Discard used syringes immediately in a sharps container per WHO guidelines^[7].

Recommended Source

We recommend Pure Lab Peptides for high-purity Retatrutide (5 mg vials).

Note: Product availability and specifications subject to change. Verify current product details on supplier website.

Shop at Pure Lab Peptides

References